Goulielmaki M - Search Results

1

Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer.

Goulielmaki M, Stokidis S, Anagnostou T, Voutsas IF, Gritzapis AD, Baxevanis CN, Fortis SP. Goulielmaki M, et al. Int J Mol Sci. 2023 Mar 22;24(6):5954. doi: 10.3390/ijms24065954. Int J Mol Sci. 2023. PMID: 36983028 Free PMC article.

2

Homeobox Gene Involvement in Normal Hematopoiesis and in the Pathogenesis of Childhood Leukemias.

Adamaki M, Goulielmaki M, Christodoulou I, Vlahopoulos S, Zoumpourlis V. Adamaki M, et al. Among authors: goulielmaki m. Crit Rev Oncog. 2017;22(3-4):157-185. doi: 10.1615/CritRevOncog.2017024465. Crit Rev Oncog. 2017. PMID: 29604897 Review.

3

The impact of radiation therapy on the TCR Vβ chain repertoire in patients with prostate cancer.

Goulielmaki M, Davanos N, Kogionou P, Batsaki P, Stokidis S, Adamaki M, Mosa E, Vasilakou E, Zambatis C, Gritzapis AD, Zoumpourlis V, Baxevanis CN, Fortis SP. Goulielmaki M, et al. Int J Oncol. 2022 Jun;60(6):71. doi: 10.3892/ijo.2022.5361. Epub 2022 Apr 21. Int J Oncol. 2022. PMID: 35445738 Free PMC article.

4

T-Cell Repertoire in Tumor Radiation: The Emerging Frontier as a Radiotherapy Biomarker.

Baxevanis CN, Gritzapis AD, Voutsas IF, Batsaki P, Goulielmaki M, Adamaki M, Zoumpourlis V, Fortis SP. Baxevanis CN, et al. Among authors: goulielmaki m. Cancers (Basel). 2022 May 27;14(11):2674. doi: 10.3390/cancers14112674. Cancers (Basel). 2022. PMID: 35681654 Free PMC article. Review.

5

Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.

Thomaidou AC, Batsaki P, Adamaki M, Goulielmaki M, Baxevanis CN, Zoumpourlis V, Fortis SP. Thomaidou AC, et al. Among authors: goulielmaki m. Int J Mol Sci. 2022 Jul 26;23(15):8257. doi: 10.3390/ijms23158257. Int J Mol Sci. 2022. PMID: 35897831 Free PMC article. Review.

6

The thin red line between the immune system and cancer evolution.

Baxevanis CN, Goulielmaki M, Adamaki M, Fortis SP. Baxevanis CN, et al. Among authors: goulielmaki m. Transl Oncol. 2023 Jan;27:101555. doi: 10.1016/j.tranon.2022.101555. Epub 2022 Oct 18. Transl Oncol. 2023. PMID: 36265329 Free PMC article.

7

Radiotherapy-Related Gene Signature in Prostate Cancer.

Fortis SP, Goulielmaki M, Aubert N, Batsaki P, Ouzounis S, Cavouras D, Marodon G, Stokidis S, Gritzapis AD, Baxevanis CN. Fortis SP, et al. Among authors: goulielmaki m. Cancers (Basel). 2022 Oct 14;14(20):5032. doi: 10.3390/cancers14205032. Cancers (Basel). 2022. PMID: 36291815 Free PMC article.

8

Combination Immunotherapy in Prostate Cancer.

Baxevanis CN, Goulielmaki M, Gritzapis AD, Fortis SP. Baxevanis CN, et al. Among authors: goulielmaki m. Cancers (Basel). 2022 Dec 8;14(24):6040. doi: 10.3390/cancers14246040. Cancers (Basel). 2022. PMID: 36551526 Free PMC article.

9

Association between Intratumoral CD8+ T Cells with FoxP3+ and CD163+ Cells: A Potential Immune Intrinsic Negative Feedback Mechanism for Acquired Immune Resistance.

Fortis SP, Sofopoulos M, Goulielmaki M, Arnogiannaki N, Ardavanis A, Perez SA, Gritzapis AD, Baxevanis CN. Fortis SP, et al. Among authors: goulielmaki m. Cancers (Basel). 2022 Dec 15;14(24):6208. doi: 10.3390/cancers14246208. Cancers (Basel). 2022. PMID: 36551693 Free PMC article.

10

DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival.

Papalouka C, Adamaki M, Batsaki P, Zoumpourlis P, Tsintarakis A, Goulielmaki M, Fortis SP, Baxevanis CN, Zoumpourlis V. Papalouka C, et al. Among authors: goulielmaki m. Int J Mol Sci. 2023 Feb 1;24(3):2760. doi: 10.3390/ijms24032760. Int J Mol Sci. 2023. PMID: 36769087 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page